• Value Research Rating market-capitalisation-info
    3 star
  • Market Capitalisation market-capitalisation-info ₹14,711 Cr
  • Price to Earnings Ratio price-to-earning 43.77
  • 12 Month Earnings monthly-earning ₹336 Cr
Value Research Rating
3 star
Quality Score fund-quick-summary-circle
8/10
Growth Score fund-quick-summary-circle
8/10
Valuation Score fund-quick-summary-circle
3/10

Neuland Laboratories Ltd. Share Price

₹11,481.55

As on 13-Aug-2024 IST

up-down-arrow-157.50-1.35%

  • Prev Close info

    11,639.05

  • Day's Openinfo

    11,649.90

  • Today's Highinfo

    11,699.00

  • Today's Lowinfo

    11,390.00

  • Today's Volumeinfo

    26,482

  • 52 Week rangeinfo

    ₹3,400.00 - 11,845.95

Please wait...

Stock Range

Today’s Range
Low 11,390.00 High: 11,699.00
52 Week Range
Low 3,400.00 High: 11,845.95
Liquidity
Low High

Neuland Laboratories Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Neuland Lab
116.99 42.13 60.81 179.30 89.62 90.00 44.60
BSE Healthcare
30.05 6.86 18.26 46.79 16.31 26.45 12.81
BSE Mid Cap
26.89 -1.61 13.94 53.62 26.75 27.88 17.84
As on 13-Aug-2024
2023
2022
2021
2020
2019
2018
2017
Neuland Lab
217.43 7.89 41.71 161.53 -12.17 -48.23 -13.51
BSE Mid Cap
45.53 1.38 39.18 19.87 -3.05 -13.31 48.13
BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Essential Checks

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Neuland Laboratories Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Neuland Laboratories Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Neuland Laboratories Ltd.

        Other details of Neuland Laboratories Ltd.

        Incorporated

        1984

        Chairman

        Davuluri Rama Mohan Rao

        Managing Director

        Davuluri Saharsh Rao

        Headquarters

        Hyderabad, Telangana

        FAQs for Neuland Laboratories Ltd.

        The total asset value of Neuland Laboratories Ltd stood at ₹ 1,833 Cr as on 30-Jun-24

        The share price of Neuland Laboratories Ltd is ₹11,481.55 (NSE) and ₹11,466.25 (BSE) as of 13-Aug-2024 IST. Neuland Laboratories Ltd has given a return of 89.62% in the last 3 years.

        Neuland Laboratories Ltd has a market capitalisation of ₹ 14,711 Cr as on 13-Aug-2024. As per Value Research classification, it is a Mid Cap company.

        The P/B ratio of Neuland Laboratories Ltd is 10.66 times as on 13-Aug-2024, a 205% premium to its peers’ median range of 3.50 times.

        The P/E ratio of Neuland Laboratories Ltd is 43.77 times as on 13-Aug-2024, a 8% discount to its peers’ median range of 47.46 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Neuland Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Neuland Laboratories Ltd.

        Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

        The promoters of Neuland Laboratories Ltd are RAMAMOHAN RAO DAVULURI and DAVULURI VIJAYA RAO. They collectively own 26.37 per cent of the total equity. The chairman of the company is Davuluri Rama Mohan Rao

        There is no promoter pledging in Neuland Laboratories Ltd.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        16,256
        1,28,227
        11,208
        8,248
        Neuland Laboratories Ltd. Ratios
        Return on equity(%)
        26.54
        Operating margin(%)
        26.09
        Net Margin(%)
        20.36
        Dividend yield(%)
        0.12

        Yes, TTM profit after tax of Neuland Laboratories Ltd was ₹336 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹14,711.07 Cr
        • Revenue (TTM)revenue-information ₹1,635.19 Cr
        • Earnings (TTM) earning-information ₹336.07 Cr
        • Cash date-information ₹116.80 Cr
        • Total Debt info ₹82.51 Cr
        • Promoters' ownership promoters_ownership 32.72%
        • Liquidity liquidity High
        • 52 Week range week-range ₹3,400.00 - 11,845.95
        • Face value face-value ₹10.00
        • Shares outstanding share-outstanding 1,28,29,889
        • 10 Years Aggregate:

          CFO: ₹983.33 Cr

          EBITDA: ₹1,487.96 Cr

          Net Profit: ₹742.64 Cr

        About The Company

        • Incorporated 1984
        • Chairman Davuluri Rama Mohan Rao
        • Managing Director Davuluri Saharsh Rao
        • Listing key-listing BSE: 524558, NSE: NEULANDLAB
        • Country India
        • Headquarters headquarters Hyderabad, Telangana
        • Website website www.neulandlabs.com
        • Business

          Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics,...  cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.  Read more